Delivery Order SPE2DB22D2211-SPE2DB25FSCQP
- Not listed
- The Defense Logistics Agency awarded a $10,218.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 180 capsules of Tavneos 10 mg, a pharmaceutical product for federal medical procurement needs. The contract is non-set-aside and competitively awarded, with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of June 17, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the drug TAVNEOS 10 MG CAPSULE 180S, with a ceiling value of $10,218.17 and a period of performance through June 4, 2025. The contract is not set aside for any particular business type. AmerisourceBergen Drug Corp is the prime contractor and holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of TAVNEOS 10 MG CAPSULE 180S, a pharmaceutical product, with a ceiling value of $10,218.17. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The award date is May 28, 2025, and the ultimate completion date is June 18, 2025. The place of performance is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 10, 2025, for Tavalisse 150 mg tablets (60-count packaging) with a ceiling value of $37,127.34. This competitively awarded, firm fixed-price delivery order is non-set-aside and scheduled for completion by October 1, 2025. The award represents a continuation of the contractor's substantial role in supporting...
- The Defense Logistics Agency awarded a delivery order valued at $22,892.70 to AmerisourceBergen Drug Corp for the supply of Tadliq 20 mg/5 ml suspension (150 ml) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen's Corporate Office is headquartered. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of FOTIVDA 0.89 mg capsules (21 count), with a ceiling value of $32,270.40 and a firm fixed price structure. This non-set-aside delivery order is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $5,966.66 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Tadliq 20 mg/5 ml Suspension in 150 ml quantities, with an ultimate completion date of August 5, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order for pharmaceutical products to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain issued a delivery order valued at $10,976.50 to AmerisourceBergen Drug Corp on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price delivery order, designated as a non-set-aside competitive award, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX). The order is to be fulfilled at AmerisourceBergen's corporate office...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,958.54 to AmerisourceBergen Drug Corp on August 13, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on June 17, 2025, for Truqap 200 mg tablets (64-count packaging). This firm fixed-price delivery order, valued at $15,514.40, is not designated as a set-aside contract and is scheduled for completion by July 10, 2025. The delivery will be performed at AmerisourceBergen's Conshohocken facility. This delivery order is...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCQPDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Tavneos 10 mg capsules (180-count units) with a ceiling value of $10,218.17. This firm fixed-price delivery order, which must be completed by September 2, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical supply vehicle enabling the company to deliver a broad range of pharmaceutical products, medical supplies, and specialty medications to support military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen regularly supplies the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through this flexible contract mechanism, demonstrating its capability to meet critical federal medical procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 8/11/25 |